⌕
IQVIA Holdings · IQV · NYSE
Tenet 44 · Weak
Compare
$264.73−0.15%At closeTenet 44 · Weak
$264.73−0.39 (−0.15%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

IQVIA Holdings (IQV) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is IQV's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Defense WorldNov 15, 2026 · 12:16 ETEARNINGS EXPECTED BY FEB 10
IQVIA Holdings Inc. $IQV Stock Holdings Increased by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. increased its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 11.4% in a recent quarter, according to its most recent 13F filing with the SEC. The firm owned 54,052 shares of the medical …

IQV −0.1% todayRead at source ↗
● Zacks Investment ResearchNov 13, 2026 · 11:16 ET
IQVIA Stock Jumps 59% in 6 Months: Here's What You Should Know

IQV's growth is fueled by rising clinical research demand, strong commercial services momentum, AI adoption and operational efficiencies that boost profitability.…

IQV −0.1% todayRead at source ↗
● Defense WorldNov 13, 2026 · 03:57 ETEARNINGS EXPECTED BY FEB 10
IQVIA Holdings Inc. $IQV Stock Holdings Decreased by CenterBook Partners LP

CenterBook Partners LP lessened its position in shares of IQVIA Holdings Inc. (NYSE: IQV) by 74.3% in a recent quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,57…

IQV −0.1% todayRead at source ↗
● Seeking AlphaNov 12, 2026 · 07:24 ETEARNINGS EXPECTED BY FEB 10
Artisan Select Equity Fund Q3 2026 Portfolio Review

Meta shares rose 29% after the company launched a new AI product called Muse, which is designed to make agentic AI capabilities accessible to ordinary consumers. IQVIA shares were up 39% as industry demand trends improve…

IQV −0.1% todayRead at source ↗
● The Motley FoolNov 9, 2026 · 20:32 ETEARNINGS EXPECTED BY FEB 10
IQVIA: 3 Key Takeaways for Long-Term Investors

Net new clinical bookings reached $3.2 billion in the third quarter. Last 12-month net new bookings increased 14% to $11.7 billion.…

IQV −0.1% todayRead at source ↗
● Seeking AlphaOct 29, 2026 · 11:20 ETEARNINGS EXPECTED BY FEB 10
Artisan Global Value Fund Q3 2026 Portfolio Discussion

US government debt-to-GDP exceeds 120%, while annual interest payments now surpass the budget for national defense. Our three best-performing stocks this quarter were Meta, IQVIA and Shell. Our three largest detractors t…

IQV −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 29, 2026 · 10:51 ET
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

IQV −0.1% todayRead at source ↗
● Defense WorldOct 28, 2026 · 04:06 ETEARNINGS EXPECTED BY FEB 10
IQVIA Holdings Inc. $IQV Stock Purchased by Citizens Financial Group Inc. RI

Citizens Financial Group Inc. RI increased its holdings in shares of IQVIA Holdings Inc. (NYSE: IQV) by 67.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exch…

IQV −0.1% todayRead at source ↗
● MarketBeatOct 27, 2026 · 16:04 ETEARNINGS EXPECTED BY FEB 10
What IQVIA (IQV) Said on Its Q3 Earnings Call

IQVIA NYSE: IQV reported third-quarter results that exceeded the high end of its guidance ranges, supported by accelerating organic growth in its Commercial Solutions and R&D Solutions businesses, higher clinical win rat…

IQV −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 27, 2026 · 11:46 ETEARNINGS EXPECTED BY FEB 10
IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y

IQV's Q3'26 earnings beat estimates as revenues rise 8% y/y, led by strong clinical demand, robust R&D bookings and improved execution, prompting a view hike.…

IQV −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 27, 2026 · 09:16 ETEARNINGS EXPECTED BY FEB 10
IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates

IQVIA Holdings (IQV) came out with quarterly earnings of $3.34 per share, beating the Zacks Consensus Estimate of $3.24 per share. This compares to earnings of $3 per share a year ago.…

IQV −0.1% todayRead at source ↗
● Business WireOct 27, 2026 · 07:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 10
IQVIA Reports Third-Quarter 2026 Results

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and h…

IQV −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 22, 2026 · 11:02 ETEARNINGS EXPECTED BY FEB 10
IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know

IQV is poised for y/y revenue and earnings growth in Q3, driven by stronger clinical research demand, solid bookings, AI adoption and operational efficiencies.…

IQV −0.1% todayRead at source ↗
● Seeking AlphaOct 20, 2026 · 11:21 ETEARNINGS EXPECTED BY FEB 10
IQVIA: R&D Bookings Are Reaccelerating, But The Valuation Now Requires Execution

IQVIA Holdings (IQV) is rated Buy, supported by strong Q2 results and a robust R&D bookings recovery. Q2 revenue grew 8.7% to $4.37B, with adjusted EPS up 12.1% and R&D net new bookings surging 19% to $3.15B. Commercial …

IQV −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 20, 2026 · 11:00 ETEARNINGS EXPECTED BY FEB 10
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

IQV −0.1% todayRead at source ↗
● Defense WorldOct 20, 2026 · 04:55 ETEARNINGS EXPECTED BY FEB 10
IQVIA Holdings Inc. $IQV Stock: Maia Wealth LLC Reduces Stake

Maia Wealth LLC trimmed its position in shares of IQVIA Holdings Inc. (NYSE: IQV) by 44.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional …

IQV −0.1% todayRead at source ↗
● Defense WorldOct 16, 2026 · 03:47 ETEARNINGS EXPECTED BY FEB 10
First Citizens Bank & Trust Co. Makes New $1.39 Million Investment in IQVIA Holdings Inc. $IQV

First Citizens Bank and Trust Co. acquired a new position in shares of IQVIA Holdings Inc. (NYSE: IQV) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm a…

IQV −0.1% todayRead at source ↗
● PRNewsWireOct 13, 2026 · 07:03 ETCOMPANY'S OWN WORDS
IQVIA Selects Veeva Clinical Operations Applications

RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif.…

IQV −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 8, 2026 · 10:50 ET
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

IQV −0.1% todayRead at source ↗
● Business WireOct 7, 2026 · 16:15 ETCOMPANY'S OWN WORDS
IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, to…

IQV −0.1% todayRead at source ↗
● Business WireOct 7, 2026 · 16:15 ETCOMPANY'S OWN WORDS
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, to…

IQV −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 2, 2026 · 12:31 ET
Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity

IQV's vast healthcare database, AI-enabled capabilities and strong R&DS bookings support growth, while low liquidity and $14.1B net debt remain in focus.…

IQV −0.1% todayRead at source ↗
● Business WireSep 9, 2026 · 17:13 ETCOMPANY'S OWN WORDS
IQVIA Announces Pricing of Senior Notes

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate princ…

IQV −0.1% todayRead at source ↗
● Business WireSep 9, 2026 · 08:15 ETCOMPANY'S OWN WORDS
IQVIA Announces Offering of Senior Notes

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 through an offering of …

IQV −0.1% todayRead at source ↗
● Business WireSep 3, 2026 · 16:15 ET
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Develop…

IQV −0.1% todayRead at source ↗
● Business WireAug 27, 2026 · 16:15 ETCOMPANY'S OWN WORDS
IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, to…

IQV −0.1% todayRead at source ↗
● Business WireAug 20, 2026 · 16:15 ET
IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, to…

IQV −0.1% todayRead at source ↗
Business Wire · Oct 27, 2026

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 10. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Article counts from the last market-wide feed page, across every symbol we track and not just IQV · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.